Patents by Inventor Abraham H. Kryger

Abraham H. Kryger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Topical testosterone formulations and associated methods
    Publication number: 20040223984
    Abstract: A topical testosterone formulation is disclosed. In one aspect, the formulation may include a therapeutically effective amount of micronized testosterone, an arginine ingredient, and a tocopherol ingredient admixed with a poloxamer lecithin organogel. Additional ingredients may be included, such as melatonin, oxytocin, DHEA, and progesterone.
    Type: Application
    Filed: January 26, 2004
    Publication date: November 11, 2004
    Inventor: Abraham H. Kryger
  • Topical testosterone formulations and associated methods
    Publication number: 20040220154
    Abstract: A topical testosterone formulation is disclosed. In one aspect, the formulation may include a therapeutically effective amount of micronized testosterone, an arginine ingredient, and a tocopherol ingredient admixed with a poloxamer lecithin organogel. Additional ingredients may be included, such as melatonin, oxytocin, DHEA, and progesterone.
    Type: Application
    Filed: January 26, 2004
    Publication date: November 4, 2004
    Inventor: Abraham H. Kryger
  • Topical testosterone formulations and associated methods
    Publication number: 20040220160
    Abstract: A topical testosterone formulation is disclosed. In one aspect, the formulation may include a therapeutically effective amount of micronized testosterone, an arginine ingredient, and a tocopherol ingredient admixed with a poloxamer lecithin organogel. Additional ingredients may be included, such as melatonin, oxytocin, DHEA, and progesterone.
    Type: Application
    Filed: January 26, 2004
    Publication date: November 4, 2004
    Inventor: Abraham H. Kryger
  • Topical testosterone formulations and associated methods
    Patent number: 6743448
    Abstract: A topical testosterone formulation is disclosed. In one aspect, the formulation may include a therapeutically effective amount of micronized testosterone, an arginine ingredient, and a tocopherol ingredient admixed with a poloxamer lecithin organogel. Additional ingredients may be included, such as melatonin, oxytocin, DHEA, and progesterone.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: June 1, 2004
    Inventor: Abraham H. Kryger
  • Topical testosterone formulations and associated methods
    Publication number: 20020150625
    Abstract: A topical testosterone formulation is disclosed. In one aspect, the formulation may include a therapeutically effective amount of micronized testosterone, an arginine ingredient, and a tocopherol ingredient admixed with a poloxamer lecithin organogel. Additional ingredients may be included, such as melatonin, oxytocin, DHEA, and progesterone.
    Type: Application
    Filed: December 11, 2001
    Publication date: October 17, 2002
    Inventor: Abraham H. Kryger